Search clinical trials for: 68Ga-FAPI

Total 644 results

Mara Veenstra, MD
UMC Utrecht; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Not yet recruiting

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma (FAPIChol)

Cholangiocarcinoma
Zhejiang University

Recruiting

A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors (CISPD-5)

Advanced Pancreatic Cancer and Cholangiocarcinoma

China
SOFIE

Recruiting

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers (18F-FAPI-74 GI)

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal Cancers

United States
The First Affiliated Hospital of Xiamen University

Recruiting

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Refractory Solid Tumor

China
Tadashi Watabe

Recruiting

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

Neoplasms

Japan
University Hospital, Essen

Completed

FAPI PET/CT Prospective Interobserver Agreement (AGREE-FAPI)

Malignant Neoplasm

Germany
Ipsen

Terminated

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

Austria
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Jonsson Comprehensive Cancer Center

Completed

Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients

Neuroendocrine Carcinoma

United States
Jilin University

Recruiting

[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity

Liver Cancer

China
Xiao Chen

Recruiting

Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies

Hepatic Malignancies

China
Erasme University Hospital

Recruiting

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases (FAPIPET)

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | FAP | Lung Fibrosis

Belgium
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Prostate

Neoplasms

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
National University Hospital, Singapore
National University, Singapore

Not yet recruiting

Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma

Hepatocellular Carcinoma
Jules Bordet Institute

Recruiting

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis (FAPeCa)

Cancer | Peritoneal Carcinomatosis

Belgium
The Affiliated Hospital of Qingdao University

Recruiting

18F-FAPI PET in the Diagnosis of Liver Fibrosis

Liver Fibrosis | Positron Emission Tomography | FAP

China
Peking Union Medical College Hospital

Active, not recruiting

Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)

Breast Cancer

China
Zhejiang University

Completed

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Diagnosis | Staging | 18F-FDG | 18F-FAPI

China
Mirati Therapeutics Inc.

Completed

A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine

Tumors

United States, Canada
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Lymphedema | Hemangioma | Arteriovenous Malformation | Neoplasms Lymph Nodes

China
Jules Bordet Institute

Recruiting

Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors (LIFE)

Non Small Cell Lung Cancer

Belgium
Affiliated Hospital of Jiangnan University

Recruiting

68Ga-labeled NY105 PET Imaging in Patients

Cancer

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Lymphoma | Leukemia | Multiple Myeloma

China
First Affiliated Hospital of Chongqing Medical...

Recruiting

68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease

Positron-Emission Tomography | FAP | PSMA

China
Affiliated Hospital of Jiangnan University

Recruiting

68Ga-labeled NY104 PET Imaging in Patients

Renal Cell Carcinoma

China
British Columbia Cancer Agency

Not yet recruiting

Dynamic Whole Body PET/ MRI

Prostatic Cancer

Canada
Massachusetts General Hospital
National Cancer Institute (NCI)

Recruiting

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Lung Cancer | Pancreas Cancer | Radiation Fibrosis | Radiation Induced Lung Injury

United States
Peking Union Medical College Hospital

Unknown

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Neuroendocrine Tumors

China
Wuhan Union Hospital, China

Recruiting

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Malignant Neoplasm

China
Peking Union Medical College Hospital

Recruiting

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

Colorectal Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

Prostate Cancer

China
Jules Bordet Institute

Withdrawn

Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management (ProsPERo)

Prostate Cancers
Peking Union Medical College Hospital

Recruiting

68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

Gastrointestinal Cancer

China
Jonsson Comprehensive Cancer Center

No longer available

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Neuroendocrine Tumors | Medullary Thyroid Cancer | Carcinoid Cancer | Cancers Expressing Somatostatin Receptors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis

Prostate Cancer Metastatic

China
Peking Union Medical College Hospital

Recruiting

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Breast Cancer | Prostate Cancer | Brain Tumor | PET/CT Imaging

China
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer

Lung Cancer | Healthy Human

China
Memorial Sloan Kettering Cancer Center
Pentixapharm AG

Recruiting

In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET

Multiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic Neoplasms

United States
Novartis Pharmaceuticals

Recruiting

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Brain Neoplasms | Glioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma

Germany, United States, France

Search clinical trials for: 68Ga-FAPI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations